PPLPHARMA — Piramal Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Piramal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,824	6,265	5,015	3,885	14,209
Net Total Accounts Receivable
Net Total Receivables	20,822	21,393	24,620	27,184	21,577
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	40,672	48,355	54,645	57,970	71,917
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	37,157	44,415	48,160	50,235	56,419
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	127,970	145,226	153,118	156,776	179,650
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30,333	38,431	43,693	37,663	47,583
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	61,004	77,491	74,004	75,521	98,024
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	66,966	67,735	79,114	81,255	81,626
Total Liabilities & Shareholders' Equity	127,970	145,226	153,118	156,776	179,650
Total Common Shares Outstanding